Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis

Journal of Craniofacial Surgery

Volumn 18, Issue 5, 2007, Pages 1071-1075

  Agrillo, Allesandro ^a   Ungari, Claudio ^a   Filiaci, Fabio ^a   Priore, Paolo ^a   Iannetti, Giorgio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bisphosphonates; Chemotherapy side effects; Oral disease; Osteonecrosis of the jaw; Ozone therapy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; AVASCULAR NECROSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INFORMED CONSENT; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; MAXILLA; MEDICAL RESEARCH; OZONE THERAPY; PRIORITY JOURNAL; SURGICAL APPROACH; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; COMBINED MODALITY THERAPY; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; OSTEONECROSIS; OXIDANTS, PHOTOCHEMICAL; OZONE;

EID: 34948821171     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/scs.0b013e31857261f     Document Type: Article

References (37)

1. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104-1107
2. Widmark G, Sagne S, Heikel P. Osteoradionecrosis of the jaws. Int J Oral Maxillofac Surg 1989;18:302
3. Morrish RB, Chan R, Silvrmann S, et al. Osteoradionecrosis in patient irradiated for head and neck carcinoma. Cancer 1981;47:1980
4. Marciani RD, Ownby HE. Osteoradionecrosis of the jaws. J Oral Maxillofac Surg 1986;44:218
5. Manz HJ, Canter HG, Melton J. Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation. South Med J 1986;79:1026
6. Bouquot JE, McMahon RE. Neuropathic pain in maxillofacial osteonecrosis. J Oral Maxillofac Surg 2000;58:1003
7. Regezi JA, Sciubba JJ. Chronic osteomyelitis. In: Regezi JA, Sciubba JJ, eds. Oral Pathology. 3rd ed. Philadelphia: WB Saunders, 1999:389
8. Thom J, Hansen HS, Specht I, et al. Osteoradionecrosis of the jaw: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 2000;58:1088
9. Urade M. Bisphosphonates and osteonecrosis of the jaws. Clin Calcium 2007;17:241-248
10. Olson KB, Hellie CM, Pienta KJ. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid. Urology 2005;66:658
11. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253-4254
12. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-1117
13. Mortensen M, Lawson W, Montazem A. Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review. Laryngoscope 2007;117:30-34
14. Agrillo A, Petrucci MT, Tedaldi M, et al. New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofacial Surg 2006;17:1080-1083
15. Pozzi S, Marcheselli R, Sacchi S, et al. Bisphosphonateassociated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients. Leuk Lymphoma 2007;48:56-64
16. Calvo-Villas JM, Tapia-Torres M, Govantes-Rodriguez J, et al. Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid. Med Clin (Barc) 2006;127:576-579
17. Drudge-Coates L. Skeletal complications and the use of bisphosphonates in metastatic prostate cancer. Int J Palliat Nurs 2006;12:462-469
18. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-1061
19. Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002;15:6538-6544
20. Marx RE, Sawatary Y, Fortin M, et al. Bisphosphonate induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575
21. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24:945-952
22. Bagan JV, Jimenez Y, Murillo J, et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-329
23. Ciriello G. L'ozonoterapia nella pratica stomatologica. Riv It Stomatol 1950;5:521-542
24. Wolff HH. Die Behandlung peripherer Durchblutungsstörungen mit Ozon. Erfahr Hk 1974;23:181-184
25. Bocci V. Does ozone therapy normalize the cellular redox balance? Med Hypotheses 1996;46:150-154
26. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 1995;19:115-119
27. Csonka C, Pataki T, Kovacs P, et al. Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic Biol Med 2000;29:612-619
28. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators of Inflammation 2004;13:3-11
29. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002;3:1129-1134
30. Babior BM, Takeuchi C, Ruedi J, et al. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci USA 2003;100:3031-3034
31. Clavo B, Catalá L, Pèrez JL, et al. Ozone therapy on cerebral blood flow: a preliminary report. Evidence-Based Complementary and Alternative Medicine 2004;1:315-319
32. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci 1999;56:270-279
33. Menendez S, Falcon L, Simon DR, et al. Efficacy of ozonized sunflower oil in the treatment of tinea pedis.Mycoses 2002;45:329-332
34. Baysan A, Whiley RA, Lynch E. Antimicrobial effect of a novel ozonegenerating device on micro-organisms associated with primary root carious lesions in vitro. Caries Res 2000;34:498-501
35. Vannucchi AM, Ficarra G, Antonioli E, et al. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 2005;128:738
36. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-534
37. Diego R, D'Orto O, Pagani D, et al. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e1-e5; Epub 2007 Jan 2